E-mail this article to
yourself or a friend.
Enter address:


Trypsin from genetically modified plants

(April 15, 2002 CropChoice news) ProdiGene, Inc. announced that it will soon be extracting a key pharmaceutical component from genetically modified plants.

Trypsin, is a protein used in cell culture and to produce pharmaceuticals, particularly insulin; it usually comes from bovine sources. ProdiGene plans to market this plant-based trypsin by the end of 2002 and achieve full-scale production shortly thereafter.

The company received a grant from the National Institutes of Health to genetically modify corn to deliver an edible AIDS vaccine.

Source: Cropbiotech Net